Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection

Journal of Hepatology

Volumn 34, Issue 5, 2001, Pages 774-779

  Wartelle Bladou, Claire ^a   Lafon, Jacques ^a   Trépo, Christian ^b   Pichoud, Christian ^b   Picon, Magali ^a   Pellissier, Jean François ^c   Zoulim, Fabien ^b  

^a CENTRE HOSPITALIER DU PAYS D AIX   (France)

^b INSERM   (France)

^c Lab Biopathologie Nerveuse M   (France)

Author keywords

Hepatitis B virus; Interferon alpha; Polyarteritis nodosa; Pre core mutant; Pre core promoter

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; HEPATITIS B CORE ANTIBODY; IMMUNOGLOBULIN M; VIRUS DNA;

AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CASE REPORT; CYTOLYSIS; FOLLOW UP; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; PATHOGENESIS; PLASMAPHERESIS; POINT MUTATION; POLYARTERITIS NODOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

ADRENAL CORTEX HORMONES; AGED; BASE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INTERFERON-ALPHA; MALE; MOLECULAR SEQUENCE DATA; PLASMA EXCHANGE; POINT MUTATION; POLYARTERITIS NODOSA; PROMOTER REGIONS (GENETICS);

EID: 0035021474     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00088-X     Document Type: Article

References (25)

1. Gocke D.J., Hsu K., Morgan C., Bombardieri S., Lockshin M., Christian C.L. Association between polyarteritis and Australia antigen. Lancet. 2:(7684):1970;1149-1153.
2. Trepo C., Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang. 19:(3):1970;410-411.
3. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 75:(1):1996;17-28.
4. Guillevin L., Lhote F., Cohen P., Sauvaget F., Jarrousse B., Lortholary O., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore). 74:(5):1995;238-253.
5. Krüger M., Böker K.H.W., Zeidler H., Manns M. Treatment of hepatitis B-related polyarteritis nodosa with Famciclovir and interferon alfa-2b. J Hepatol. 26:1997;935-939.
6. Wicki J., Olivieri J., Pizzolato G., Sarasin F., Guillevin L., Dayer J.M., et al. Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Letter Rheumatology (Oxford). 38:(2):1999;183-185.
7. Maclachlan D., Battegay M., Jacob A.L., Tyndall A. Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report. Letter Rheumatology (Oxford). 39:(1):2000;106-108.
8. Miguelez M., Bueno J., Laynez P. Polyarteritis nodosa associated with precore mutant hepatitis B virus infection. Letter Ann Rheum Dis. 57:(3):1998;173.
9. Lightfoot R.W. Jr, Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., McShane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 33:(8):1990;1088-1093.
10. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 68:1994;8102-8110.
11. Norder H., Couroucé A-M., Magnius L. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology. 198:1994;489-503.
12. Pichoud C., Berby F., Stuyver L., Petit M.A., Trepo C., Zoulim F. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B. J Hepatol. 32:(2):2000;307-316.
13. Prince A.M., Trepo C. Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet. 1:(7713):1971;1309-1312.
14. Trepo C.G., Magnius L.O., Schaefer R.A., Prince A.M. Detection of e antigen and antibody: correlations with hepatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections. Gastroenterology. 71:(5):1976;804-808.
15. Neurath A.R., Trepo C., Chen M., Prince A.M. Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol. 30:(3):1976;277-285.
16. Buckwold V.E., Xu Z., Chen M., Yen T.S.B., Ou J.-H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol. 70:1996;5845-5851.
17. Trepo C., Ouzan D., Delmont J., Tremisi J. Superiority of a new etiopathogenic treatment curing periarteritis nodosa caused by hepatitis B virus, using a combination of brief corticotherapy, vidarabine and plasma exchange. Presse Med. 17:(30):1988;1527-1531.
18. Guillevin L., Lhote F., Leon A., Fauvelle F., Vivitski L., Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol. 20:(2):1993;289-298.
19. Avsar E., Savas B., Tozun N., Ulusoy N.B., Kalayci C. Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first-line therapy. Letter J Hepatol. 28:(3):1998;525-526.
20. Lampertico P., Del Ninno E., Manzin A., Donato M.F., Rumi M.G., Lunghi G., et al. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology. 26:(6):1997;1621-1625.
21. Zhang X., Zoulim F., Habersetzer F., Xiong S., Trépo C. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. J Med Virol. 48:1996;8-16.
22. Günther S., Fischer L., Pult I., Sterneck M., Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res. 52:1999;25-137.
23. Grandjacques C., Pradat P., Stuyver L., Chevallier M., Chevallier P., Pichoud C., et al. Rapid detection of mutations in the promoter and the pre-core region of HBV genome: correlation with viral persistence and disease activity. J Hepatol. 33:2000;430-439.
24. Tassopoulos N.C., Volpes R., Pastore G., Heathcote J., Buti M., Goldin R.D., et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/Hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. In process citation Hepatology. 29:(3):1999;889-896.
25. Erhardt A., Sagir A., Guillevin L., Neuen-Jacob E., Haussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. J Hepatol. 33:2000;677-683.